4.7 Review

The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

Amit G. Singal et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis with survival rates below 20% in 5 years, partly due to failures in the cancer screening process continuum. A conceptual model outlining discrete steps in the HCC screening process highlights delays or failures at each step and identifies factors contributing to these failures at the patient, provider, and health care system levels. Comparing HCC screening processes with breast and colorectal cancer screening can help identify opportunities for improvement and ultimately improve early detection of HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism

Jonas Norskov Sondergaard et al.

Summary: By globally characterizing RNA-binding proteins (RBPs), we revealed the perturbation of RBP gene expression in hepatocellular carcinoma (HCC) and identified their additional functions in tumor growth regulation, particularly in lipid metabolism. Furthermore, the interaction between non-canonical RBP CCT3 and LINC00326 was found to be involved in the regulation of lipid accumulation and degradation, affecting HCC cell phenotype and tumour growth in vivo.
Article Gastroenterology & Hepatology

DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis

Hong-Zhong Zhou et al.

Summary: This study found a higher frequency of alternative splicing events in HCC tissues with extrahepatic metastasis compared to metastasis-free tissues. DDX17 and PXN-AS1-IR3 act as important metastatic promoters by modulating MYC signaling, suggesting they may be potential prognostic markers for metastatic HCC.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions

Jack Leslie et al.

Summary: HCV hijacks host metabolic processes to aid in viral replication, resulting in hepatic and extrahepatic metabolic dysfunction. Obesity, insulin resistance, and hepatic steatosis play key roles in the progression of chronic hepatitis C (CHC) to hepatocellular carcinoma (HCC). While direct-acting antivirals (DAAs) effectively eliminate the virus, long-lasting metabolic diseases can persist, particularly in the presence of obesity, increasing the risk of liver disease progression.

JOURNAL OF HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCC

Kevin Zhou et al.

MOLECULAR CANCER (2022)

Article Biochemistry & Molecular Biology

Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA

Ying Zhang et al.

Summary: This study reveals the important role of NEAT1 in regulating ferroptosis in tumors, and enhances the effect of ferroptosis by modulating miR-362-3p and MIOX. Therefore, ferroptosis induction may be a promising therapeutic strategy for HCC patients with high NEAT1 expression.

CELL DEATH AND DIFFERENTIATION (2022)

Article Gastroenterology & Hepatology

Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance

Ryan A. Hlady et al.

Summary: Chronic HCV infection significantly impacts the epigenome, especially enhancers; HCV shares epigenetic targets with interferon-alpha; the majority of epigenetic changes induced by HCV persist as scars on the epigenome after viral cure.

HEPATOLOGY (2022)

Review Oncology

The potential role of N-7-methylguanosine (m7G) in cancer

Yuejun Luo et al.

Summary: N-7-methylguanosine (m7G) is a prevalent RNA modification that actively participates in biological and pathological functions. It plays a critical role in cancer development and is closely associated with tumorigenesis and progression. The underlying molecular mechanisms of m7G in cancer are not fully understood.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Review Cell Biology

Cell cycle control in cancer

Helen K. Matthews et al.

Summary: This review highlights the importance of cell cycle regulation in preventing genetic errors and cell proliferation, and how disruption of these mechanisms is associated with cancer development. Cancer arises from continuous cell division and evasion of cell cycle control mechanisms.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Review Biotechnology & Applied Microbiology

Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment

Zijie Xu et al.

Summary: Exosomes play a crucial role in intercellular communication, especially in interactions between tumor cells and tumor-associated macrophages (TAMs). Exosome-encapsulated non-coding RNAs (ncRNAs) are involved in various physiological processes, regulating tumor proliferation, metastasis, angiogenesis, chemoresistance, and immunosuppression. The effects of exosomal ncRNAs on immune cells contribute to T cell exhaustion and the creation of a tumor immunosuppressive microenvironment.

MOLECULAR THERAPY (2022)

Review Food Science & Technology

Plant-based foods and hepatocellular carcinoma: A review on mechanistic understanding

Raakia Anam Saeed et al.

Summary: Regardless of the cause, hepatocarcinogenesis typically involves chronic necroinflammation, hepatic regeneration, hepatic fibrosis, and cirrhosis. The liver plays a crucial role in maintaining immunotolerance, and any dysregulation of this process is a hallmark of chronic liver disease and hepatocellular carcinoma (HCC). HCC accounts for 90% of liver cancers, and emerging evidence suggests that diet is a lifestyle-associated risk factor for its development. Natural compounds have shown potential in inhibiting cellular proliferation and modulating oncogenic pathways to fight against hepatoma aggressiveness. This review aims to identify plant-based foods and understand their molecular mechanisms in preventing HCC. The inclusion of these foods in the diet may not only improve overall health but also reduce the incidence of cancer.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Article Food Science & Technology

Whole-Transcriptome Analysis of Non-Coding RNA Alteration in Porcine Alveolar Macrophage Exposed to Aflatoxin B1

Huhe Chao et al.

Summary: The exposure to AFB1 impairs the proliferation of 3D4/2 cells and induces apoptosis through the non-coding RNA-mediated pathway.

TOXINS (2022)

Article Endocrinology & Metabolism

Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma

Fangzhou Liu et al.

Summary: Alterations in cholesterol homeostasis may contribute to hepatic cancer aggressiveness. The long non-coding RNA SNHG6 is found to be an important player in this process, linking cholesterol sensing with cancer cell growth through mTORC1 signaling. SNHG6 modulates cholesterol-induced mTORC1 activation by forming a SNHG6-FAF2-mTOR complex, enhancing cholesterol-dependent mTORC1 lysosomal recruitment and activation. Loss of SNHG6 inhibits mTORC1 signaling and impairs liver cancer tumor growth, suggesting SNHG6 as a potential target for liver cancer treatment.

NATURE METABOLISM (2022)

Article Medicine, Research & Experimental

mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma

Hong Zhang et al.

Summary: This study reveals the molecular mechanism by which mTOR promotes the "Warburg Effect" in HCC, which is important for the metabolism and development of HCC, as well as the anticancer response of mTOR-targeted therapy.

THERANOSTICS (2022)

Review Oncology

Exploiting senescence for the treatment of cancer

Liqin Wang et al.

Summary: This review discusses how senescence can be induced in cancer cells and how the distinctive features of senescent cancer cells can be exploited for selective eradication. It also explores activation of the host immune system as an attractive way to clear senescent cancer cells, and the potential benefits of a sequential treatment approach with pro-senescence therapy followed by senolytic therapy.

NATURE REVIEWS CANCER (2022)

Review Gastroenterology & Hepatology

Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma

Joseph C. Ahn et al.

Summary: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and mortality worldwide, and current tests like alpha-fetoprotein have limited accuracy. Liver biopsy, while informative, is not routinely used due to invasiveness, leading to a need for new biomarkers. Liquid biopsy, specifically detection of circulating tumor cells (CTCs), offers potential for early detection and personalized treatment management in HCC patients. Quantitative analysis of CTCs can predict disease prognosis and treatment response, highlighting the importance of developing CTC detection platforms for clinical use.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Biomarkers for Hepatobiliary Cancers

Jean-Charles Nault et al.

Summary: The clinical management of primary liver cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) has significantly changed in the last 3 years due to the introduction of systemic therapies. Biomarkers play a crucial role in improving patient stratification and maximizing clinical benefits. While progress in understanding the molecular alterations of HCC is lagging, several therapeutic targets have been identified in CCA, with biomarker-driven therapies currently under evaluation in clinical trials.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Tobacco, Cigarettes, and the Liver: The Smoking Gun

Madhumita Premkumar et al.

Summary: Smoking is independently associated with liver fibrosis and contributes to carcinogenesis in hepatocellular carcinoma. Heavy smoking can lead to systemic inflammation, oxidative stress, and tissue damage, while also increasing the risk of various types of cancers and vascular diseases.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Ubiquitination in the regulation of inflammatory cell death and cancer

Peter E. Cockram et al.

Summary: The ubiquitin system is crucial for the modulation of cellular processes, including programmed cell death and inflammation. It controls protein degradation, cellular processes, and plays a key role in various diseases such as cancer.

CELL DEATH AND DIFFERENTIATION (2021)

Review Cell Biology

Sweet death: Fructose as a metabolic toxin that targets the gut-liver axis

Mark A. Febbraio et al.

Summary: Fructose is closely related to metabolic diseases, with consumption of high-fructose corn syrup correlating with increased rates of obesity and diabetes. In addition to being metabolized in the liver, fructose has been found to be metabolized in the small intestine, leading to deterioration of the intestinal epithelial barrier. The gut-liver axis plays a key role in fructose metabolism and pathology, along with the direct effects of fructose on liver metabolism.

CELL METABOLISM (2021)

Review Pharmacology & Pharmacy

Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine

Vikas Kumar et al.

Summary: Hepatocellular carcinoma is a major health issue worldwide, with traditional therapies showing sub-optimal responses. Nanomedicine has attracted attention for its target-specific drug delivery and minimal toxicity.

EXPERT OPINION ON DRUG DELIVERY (2021)

Article Gastroenterology & Hepatology

Inhibition of Long Noncoding RNA Linc-Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis

Mousumi Khatun et al.

Summary: This study revealed that HCV exploits Linc-Pint in hepatocytes to enhance lipogenesis, shedding light on its role in virus replication and liver disease progression.

HEPATOLOGY (2021)

Review Pharmacology & Pharmacy

Anticancer drug resistance: An update and perspective

Ruth Nussinov et al.

Summary: Driver mutations play a critical role in cancer initiation and progression, with drug resistance being a common challenge in pharmacological treatment. The emergence of drug resistance can be attributed to a variety of mechanisms, such as mutations occurring in the same or different proteins, and in the same or parallel pathways. The complexity of genetic alterations and tumor microenvironment changes poses challenges in predicting drug resistance and requires further research in precision medicine.

DRUG RESISTANCE UPDATES (2021)

Article Chemistry, Multidisciplinary

Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy

Bingling Lin et al.

Summary: A theranostic nanomedicine has been developed to co-deliver super-paramagnetic iron oxide nanoparticles (SPIO) and small interfering RNA/antisense oligonucleotides (siRNA/ASO) targeting Pnky long noncoding RNA (lncRNA) into neural stem cells (NSCs). This nanomedicine promotes neuronal differentiation of NSCs by silencing the Pnky lncRNA, while also enabling in vivo tracking of NSCs with improved magnetic resonance imaging. The enhanced neuronal differentiation of NSCs leads to structural and functional recovery of the damaged brain after a stroke, demonstrating potential for enhancing stem cell-based therapies for stroke.

NANO LETTERS (2021)

Article Biochemistry & Molecular Biology

Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data

Yue Gao et al.

Summary: The updated Lnc2Cancer 3.0 database provides comprehensive data on experimentally supported long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) associated with human cancers, including a wide range of cancer subtypes. The database also offers web tools for analyzing and visualizing lncRNA expression in cancers.

NUCLEIC ACIDS RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Gastroenterology & Hepatology

DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes

Lea Meunier et al.

Summary: This study reveals the diverse processes remodeling HCC methylomes and the epigenetic and transcriptional impact of driver alterations. MethICA identified stable methylation components preferentially active in specific chromatin states, sequence contexts, and replication timings, shedding light on the underlying molecular mechanisms in tumors. Mutations in key genes like catenin beta 1 and AT-rich interactive domain-containing protein 1A were shown to modulate methylation patterns and affect differentiation-promoting transcriptional networks.

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial

Man-Fung Yuen et al.

Summary: Chronic infection with hepatitis B virus (HBV) poses a high risk of death from cirrhosis and hepatocellular carcinoma. Current treatment options have low functional cure rates. Bepirovirsen, an antisense oligonucleotide, shows promise in reducing HBV-derived RNAs, HBV DNA, and viral proteins. Preliminary observations from a phase 2 trial suggest that bepirovirsen has a favorable safety profile and can significantly reduce HBsAg concentrations in some patients. Further investigation in a larger population is warranted.

NATURE MEDICINE (2021)

Review Physiology

REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2

Angelia Szwed et al.

Summary: Cells metabolize nutrients for growth and proliferation, with mTOR playing a key role in integrating growth and metabolism through the protein complexes mTORC1 and mTORC2. Study of mTORC1 and mTORC2 has expanded our understanding of cellular metabolism regulation and functions.

PHYSIOLOGICAL REVIEWS (2021)

Review Genetics & Heredity

Long Noncoding RNAs at the Crossroads of Cell Cycle and Genome Integrity

Giulia Guiducci et al.

Summary: This article discusses the involvement of lncRNAs in cell cycle control and maintenance of genome stability, while also highlighting how changes in lncRNA regulatory networks can lead to proliferative diseases such as cancer.

TRENDS IN GENETICS (2021)

Article Multidisciplinary Sciences

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand

Lei Wei et al.

Summary: The formation of HBV covalently closed circular DNA (cccDNA) is crucial for chronic infection, but the molecular mechanism behind it is unclear. Researchers found that the repair of plus-strand and minus-strand lesions of HBV rcDNA during the conversion to cccDNA requires different sets of human repair factors.

NATURE COMMUNICATIONS (2021)

Review Oncology

Metabolic Codependencies in the Tumor Microenvironment

Prasenjit Dey et al.

Summary: Cancer cell metabolic reprogramming is driven by signals from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, while extrinsic signals fine-tune metabolic processes based on metabolite availability and cellular requirements. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on cancer genotype, tumor microenvironment composition, and tissue location.

CANCER DISCOVERY (2021)

Article Chemistry, Multidisciplinary

LncRNA Lnc-APUE is Repressed by HNF4α and Promotes G1/S Phase Transition and Tumor Growth by Regulating MiR-20b/E2F1 Axis

Song-Yang Li et al.

Summary: A novel long noncoding RNA called lnc-APUE was discovered, which accelerates cell proliferation in various types of cancer by binding to miR-20b and enhancing E2F1 expression. This study revealed a new axis involving HNF4 alpha/lnc-APUE/miR-20b/E2F1 in tumor cells, where HNF4 alpha repression leads to increased lnc-APUE expression and subsequent promotion of cell cycle progression and tumor growth.

ADVANCED SCIENCE (2021)

Review Immunology

Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer

Xueke Wang et al.

Summary: HCC, the most deadly malignant tumor globally, is closely associated with HBV, and lncRNA imbalance is a key factor in its development. Through studying the interaction between lncRNAs and DNA, RNA, or proteins, researchers can uncover crucial mechanisms in HCC progression. Dysfunctional lncRNAs in HBV-related HCC play significant roles in the regulation and potential molecular mechanisms of tumor occurrence and development.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Oncology

Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Yueying Qi et al.

Summary: This study aims to clarify the main risk factors of type 2 diabetes mellitus with nonalcoholic fatty liver disease and hepatocellular carcinoma, as well as the challenges in diagnosis and treatment. The current gold standard is to adjust treatment strategies, optimize metabolic control, and improve liver phenotype in managing these conditions. Identifying further risk factors and assessing new therapeutic targets are necessary for addressing the progression of these diseases.

JOURNAL OF ONCOLOGY (2021)

Review Oncology

Nutritional therapy for hepatocellular carcinoma

Astrid Ruiz-Margain et al.

Summary: Patients with hepatocellular carcinoma (HCC) should receive special attention to nutritional support, including assessment and treatment for malnutrition. In addition to traditional methods, functional testing and computed tomography scans are important tools for nutritional assessment. Nutritional therapy should focus on providing adequate energy and protein, along with supplementation of branched-chain amino acids and encouragement of physical exercise.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Review Oncology

The Role of the Microbiome in Liver Cancer

Mar Moreno-Gonzalez et al.

Summary: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major cause of cancer-related deaths globally. Increasing evidence shows that changes in intestinal microbiota composition and function are associated with HCC progression, contributing to liver cirrhosis and inflammatory responses. Therapeutic strategies involving modification of the microbiome have shown potential in reducing inflammation and fibrosis in chronic liver disease and HCC.

CANCERS (2021)

Article Oncology

LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2

Dan Yin et al.

Summary: In hepatocellular carcinoma (HCC), genomic copy numbers of LINC01133 are increased and positively correlated with its expression. Higher copy number of LINC01133 predicts a poor prognosis in HCC patients. LINC01133 promotes HCC progression by sponging miR-199a-5p and interacting with ANXA2.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Pharmacology & Pharmacy

Nanomedicine at the crossroads - A quick guide for IVIVC

Marc-Phillip Mast et al.

Summary: Nanomedicine has been pushing the boundaries of drug delivery for many years, with a focus on safety considerations during clinical trials and product development. There is potential for nanomedicine to expand beyond niche markets and gain broader acceptance in the pharmaceutical industry. However, challenges arise in translating new drug delivery systems like extracellular vesicles from the lab to the bedside, highlighting the need for further research and learning from past experiences.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Oncology

Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma

Juan P. Unfried et al.

Summary: NIHCOLE is a novel lncRNA induced in hepatocellular carcinoma (HCC) with oncogenic potential, playing a crucial role in DNA repair and cellular fitness, making it a potential therapeutic target for HCC treatment.

CANCER RESEARCH (2021)

Article Chemistry, Physical

Obstacles and opportunities in a forward vision for cancer nanomedicine

Irene de Lazaro et al.

Summary: This text discusses the biological barriers that have hindered the clinical translation of cancer nanomedicines, and elaborates on new directions for the field that capitalize on a deeper understanding of the nano-bio interface.

NATURE MATERIALS (2021)

Review Gastroenterology & Hepatology

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications

Terence Kin-Wah Lee et al.

Summary: Hepatocellular carcinoma (HCC) is an aggressive disease with poor prognosis, powered by a subset of cancer stem cells (CSCs). Research on liver CSCs has revealed their heterogeneity and unique immunobiology, suggesting potential for new research directions and therapies for HCC.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Cell Biology

The Cancer SENESCopedia: A delineation of cancer cell senescence

Fleur Jochems et al.

Summary: The study comprehensively analyzed the transcriptome and senolytic responses in 13 cancer cell lines induced to undergo senescence, showing that the response to senolytic agents and the composition of the senescence-associated secretory phenotype in cancer cells are more influenced by the cell of origin than by the senescence trigger. Using machine learning, a gene expression classifier called SENCAN was established for detecting senescence in cancer cell samples, with the expression profiles and classifier accessible online as Cancer SENESCopedia.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis

Meng-Zhi Wu et al.

Summary: This study identified an oncogenic lncRNA, lnc-UTGF, that is upregulated in HCC and transcriptionally induced by TGF-beta. Mechanistic investigations revealed a positive feedback loop between TGF-beta/SMAD signaling and lnc-UTGF, promoting hepatoma metastasis. The findings suggest lnc-UTGF as a potential therapeutic target for HCC metastasis.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Cancer metabolism: looking forward

Inmaculada Martinez-Reyes et al.

Summary: This Perspective discusses the main themes in cancer metabolism research, focusing on the relationship between tumour initiation and progression with metabolic reprogramming, as well as the importance of tumor microenvironment and metabolic regulation.

NATURE REVIEWS CANCER (2021)

Review Oncology

Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine

Nurbubu T. Moldogazieva et al.

Summary: Liquid biopsy is a novel, minimally invasive approach for monitoring tumor progression, metastasis, and recurrence in hepatocellular carcinoma (HCC), but it presents a risk of bias in early detection due to its relatively high specificity and low sensitivity. Next-generation sequencing technologies offer accurate and comprehensive analysis of gene expression and mutational profiling in liquid biopsies, potentially enhancing precision oncology capabilities in HCC patients with varying genomic signatures.

CANCER GENOMICS & PROTEOMICS (2021)

Review Biochemical Research Methods

The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years

Song Zhang et al.

Summary: This article discusses the role of nucleic acids in gene expression regulation, particularly in protein synthesis and malignant diseases. It focuses on the challenges of hepatocellular carcinoma in diagnosis and therapy, and provides the latest research progress on nucleic acids for therapeutic and diagnostic purposes in this field.

BRIEFINGS IN BIOINFORMATICS (2021)

Review Oncology

The language of chromatin modification in human cancers

Shuai Zhao et al.

Summary: The deregulation of chromatin modification underlies numerous oncogenic processes, contributing to cancer development by inducing epigenetic, transcriptomic, and phenotypic alterations. Understanding and developing more effective drugs to target these chromatin-related vulnerabilities will enhance the treatment of human malignancies. This review synthesizes the connections between chromatin modifications and cancer, highlighting options for therapeutic targeting based on recent advances.

NATURE REVIEWS CANCER (2021)

Review Oncology

Long noncoding RNAs in cancer metastasis

S. John Liu et al.

Summary: Long noncoding RNAs play crucial roles in promoting metastasis by participating in discrete pro-metastatic steps and influencing the metastatic tumor microenvironment. They have the potential for diagnostic and therapeutic applications, but also face controversies and ongoing technical challenges. Further research is needed to explore their mechanisms and potential as targets for novel therapies in cancer metastasis.

NATURE REVIEWS CANCER (2021)

Review Oncology

Group Behavior and Emergence of Cancer Drug Resistance

Supriyo Bhattacharya et al.

Summary: Drug resistance in cancer is caused by both genetic mutations and non-genetic mechanisms, with intermediate reversible phenotypes playing a crucial role in the emergence of resistant clones. Understanding the complex interplay of clonal groups and the surrounding microenvironment can help in designing more effective treatment strategies to delay or minimize drug resistance.

TRENDS IN CANCER (2021)

Review Biochemistry & Molecular Biology

Ubiquitin signaling in cell cycle control and tumorigenesis

Fabin Dang et al.

Summary: Cell cycle progression relies on the activation of cyclin-dependent kinases, regulated in part by ubiquitin-mediated proteolysis. Dysregulated proteolytic control can lead to uncontrolled cell proliferation and tumorigenesis. Targeting E3 ubiquitin ligases involved in cell cycle regulation may offer novel therapeutic strategies for cancer treatment.

CELL DEATH AND DIFFERENTIATION (2021)

Article Medicine, Research & Experimental

Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2

Xiaohong Xiang et al.

Summary: This study identified PINT87aa as a novel biomarker and key regulator of cellular senescence in HCC, highlighting its potential as a therapeutic target for HCC.

THERANOSTICS (2021)

Review Biochemical Research Methods

Decoding competing endogenous RNA networks for cancer biomarker discovery

Xin Qi et al.

BRIEFINGS IN BIOINFORMATICS (2020)

Article Chemistry, Multidisciplinary

Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier

Hyun Su Min et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Biochemistry & Molecular Biology

LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles

Tao Guo et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Pharmacology & Pharmacy

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

Silpa Narayanan et al.

DRUG RESISTANCE UPDATES (2020)

Review Biochemistry & Molecular Biology

Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application

Le Zhang et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis

Yun-feng Guan et al.

ONCOGENE (2020)

Article Biochemistry & Molecular Biology

Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol

Keigo Machida

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Review Biochemistry & Molecular Biology

The role of long noncoding RNAs in hepatocellular carcinoma

Zhao Huang et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis

Wei-Juan Huang et al.

ONCOGENE (2020)

Review Biochemistry & Molecular Biology

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease

Hideki Fujii et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment

Wenyu Wang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Cell Biology

EMT, MET, Plasticity, and Tumor Metastasis

Basil Bakir et al.

TRENDS IN CELL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Targeting STAT3 in Cancer Immunotherapy

Sailan Zou et al.

MOLECULAR CANCER (2020)

Review Biochemistry & Molecular Biology

The role of ubiquitination and deubiquitination in cancer metabolism

Tianshui Sun et al.

MOLECULAR CANCER (2020)

Article Multidisciplinary Sciences

Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma

Qingmiao Shi et al.

SCIENTIFIC REPORTS (2020)

Article Chemistry, Multidisciplinary

A p53/lnc-Ip53 Negative Feedback Loop Regulates Tumor Growth and Chemoresistance

Li-Zhen Zhang et al.

ADVANCED SCIENCE (2020)

Article Genetics & Heredity

RNA, Genome Output and Input

Jorg Morf et al.

FRONTIERS IN GENETICS (2020)

Review Oncology

Role of RNA modifications in cancer

Isaia Barbieri et al.

NATURE REVIEWS CANCER (2020)

Review Biochemistry & Molecular Biology

Exosomes: key players in cancer and potential therapeutic strategy

Jie Dai et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Medicine, Research & Experimental

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling

Ji Liu et al.

THERANOSTICS (2020)

Review Biochemical Research Methods

The small peptide world in long noncoding RNAs

Seo-Won Choi et al.

BRIEFINGS IN BIOINFORMATICS (2019)

Review Cell Biology

Interchromosomal interactions: A genomic love story of kissing chromosomes

Philipp G. Maass et al.

JOURNAL OF CELL BIOLOGY (2019)

Review Medicine, Research & Experimental

Genome-wide methods for investigating long noncoding RNAs

Mei Cao et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Food Science & Technology

Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods

Blake R. Rushing et al.

FOOD AND CHEMICAL TOXICOLOGY (2019)

Review Oncology

Ferroptosis, a new form of cell death: opportunities and challenges in cancer

Yanhua Mou et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis

Yufeng Wang et al.

MOLECULAR CANCER (2019)

Review Biochemistry & Molecular Biology

Global Positioning System: Understanding Long Noncoding RNAs through Subcellular Localization

Joana Carlevaro-Fita et al.

MOLECULAR CELL (2019)

Review Nutrition & Dietetics

Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases

Sabrina Campisano et al.

NUTRITION RESEARCH REVIEWS (2019)

Review Medical Laboratory Technology

Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma

Roseane Guimaraes Ferreira et al.

TRANSLATIONAL RESEARCH (2019)

Review Genetics & Heredity

Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis

Amanda K. McCullough et al.

DNA REPAIR (2019)

Review Gastroenterology & Hepatology

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction

Fasiha Kanwal et al.

GASTROENTEROLOGY (2019)

Editorial Material Gastroenterology & Hepatology

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma

Renumathy Dhanasekaran et al.

HEPATOLOGY (2019)

Review Biochemistry & Molecular Biology

Mechanisms associated with biogenesis of exosomes in cancer

Kathleen M. McAndrews et al.

MOLECULAR CANCER (2019)

Review Cell Biology

RNA modifications regulating cell fate in cancer

Sylvain Delaunay et al.

NATURE CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling

Yanying Wang et al.

EMBO JOURNAL (2019)

Review Biochemistry & Molecular Biology

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

Qianwei Ye et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma

Li Zhang et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

An LTR retrotransposon-derived lncRNA interacts with RNF169 to promote homologous recombination

Bing Deng et al.

EMBO REPORTS (2019)

Review Biochemistry & Molecular Biology

Alcohol or Gut Microbiota: Who Is the Guilty?

Marica Meroni et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Chemistry, Multidisciplinary

Recent Progress in Ferroptosis Inducers for Cancer Therapy

Chen Liang et al.

ADVANCED MATERIALS (2019)

Article Nanoscience & Nanotechnology

Smart cancer nanomedicine

Roy van der Meel et al.

NATURE NANOTECHNOLOGY (2019)

Article Gastroenterology & Hepatology

Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy

Mizuki Nishibatake Kinoshita et al.

JOURNAL OF HEPATOLOGY (2019)

Review Genetics & Heredity

Current and future perspectives of liquid biopsies in genomics-driven oncology

Ellen Heitzer et al.

NATURE REVIEWS GENETICS (2019)

Review Biochemistry & Molecular Biology

Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches

Xingyang Qian et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

Article Medicine, Research & Experimental

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription

Chun Lan Kang et al.

THERANOSTICS (2019)

Article Medicine, Research & Experimental

LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer

Jinyan Feng et al.

THERANOSTICS (2019)

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

Article Biochemistry & Molecular Biology

Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide

Sang-Soo Kim et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biochemistry & Molecular Biology

Noncoding RNA:RNA Regulatory Networks in Cancer

Jia Jia Chan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a

Xiaoru Xin et al.

MOLECULAR CANCER (2018)

Article Biochemistry & Molecular Biology

Functional Domains of NEAT1 Architectural lncRNA Induce Paraspeckle Assembly through Phase Separation

Tomohiro Yamazaki et al.

MOLECULAR CELL (2018)

Review Biotechnology & Applied Microbiology

RNA-modifying proteins as anticancer drug targets

P. Ann Boriack-Sjodin et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Pharmacology & Pharmacy

Biogenesis and function of extracellular vesicles in cancer

Maarten P. Bebelman et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Cell Biology

Long Noncoding RNA in Cancer: Wiring Signaling Circuitry

Chunru Lin et al.

TRENDS IN CELL BIOLOGY (2018)

Article Medicine, General & Internal

Hepatitis B virus infection

Nature Reviews Disease Primers (2018)

Article Medicine, General & Internal

Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma

Zijun Xie et al.

EBIOMEDICINE (2018)

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Oncology

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

Tracey G. Simon et al.

JAMA ONCOLOGY (2018)

Article Biochemical Research Methods

Long noncoding RNA: a crosslink in biological regulatory network

Yuwei Zhang et al.

BRIEFINGS IN BIOINFORMATICS (2018)

Article Gastroenterology & Hepatology

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

Pietro Carotenuto et al.

Review Biochemistry & Molecular Biology

Non- metabolic functions of glycolytic enzymes in tumorigenesis

X. Yu et al.

ONCOGENE (2017)

Review Biochemistry & Molecular Biology

LncRNA-mediated regulation of cell signaling in cancer

W-X Peng et al.

ONCOGENE (2017)

Review Pathology

Cancer Stem Cells: Basic Concepts and Therapeutic Implications

Dany Nassar et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Article Cell Biology

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

Shang-Jui Wang et al.

CELL REPORTS (2016)

Article Oncology

Autophagy, Metabolism, and Cancer

Eileen White et al.

CLINICAL CANCER RESEARCH (2015)

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice

Amit G. Singal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

Article Genetics & Heredity

The landscape of long noncoding RNAs in the human transcriptome

Matthew K. Iyer et al.

NATURE GENETICS (2015)

Editorial Material Gastroenterology & Hepatology

HEPATITIS Epigenetic control of HBV by HBx protein-releasing the break?

Ulrike Protzer

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Review Cell Biology

Cellular senescence: from physiology to pathology

Daniel Munoz-Espin et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Signaling through cyclin D-dependent kinases

Y. J. Choi et al.

ONCOGENE (2014)

Article Gastroenterology & Hepatology

Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants

H. V. Tong et al.

JOURNAL OF VIRAL HEPATITIS (2013)

Review Gastroenterology & Hepatology

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma

Avijit Majumdar et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)

Article Biochemistry & Molecular Biology

ENCODE whole-genome data in the UCSC Genome Browser: update 2012

Kate R. Rosenbloom et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Oncology

SHP-1 in Cell-Cycle Regulation

Pilar Lopez-Ruiz et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)

Review Cell Biology

NF-kappa B and STAT3 - key players in liver inflammation and cancer

Guobin He et al.

CELL RESEARCH (2011)

Review Genetics & Heredity

Role of cancer stem cells in hepatocarcinogenesis

Bo Wang et al.

GENOME MEDICINE (2011)

Review Biotechnology & Applied Microbiology

Long intronic noncoding RNA transcription: Expression noise or expression choice?

Rodrigo Louro et al.

GENOMICS (2009)

Review Oncology

STATs in cancer inflammation and immunity: a leading role for STAT3

Hua Yu et al.

NATURE REVIEWS CANCER (2009)

Article Biochemistry & Molecular Biology

The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis

Marie-Julie Dubois et al.

NATURE MEDICINE (2006)

Article Gastroenterology & Hepatology

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

JA Marrero et al.

JOURNAL OF HEPATOLOGY (2005)

Article Genetics & Heredity

DNA double-strand breaks: signaling, repair and the cancer connection

KK Khanna et al.

NATURE GENETICS (2001)